KarXT — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-10-05 in 2mo
ESTIMATED |
READOUT
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis As
Phase 3 · Psychosis Associated With Alzheimer's Disease |
Karuna Therapeutics, Inc., a Brist | KarXT |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|
| 2026-11-01 in 3mo
ESTIMATED |
READOUT
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic
Phase 3 · Bipolar-I Disorder With Mania or Mania With Mixed Features |
BMY BRISTOL MYERS SQUIBB CO | KarXT |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|
| 2026-11-02 in 3mo
ESTIMATED |
READOUT
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic
Phase 3 · Bipolar Disorder Type I With Mania or Mania With Mixed Features |
BMY BRISTOL MYERS SQUIBB CO | KarXT |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|
| 2026-11-24 in 4mo
ESTIMATED |
READOUT
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer
Phase 3 · Alzheimer Disease |
Karuna Therapeutics, Inc., a Brist | KarXT |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|
| 2026-12-09 in 4mo
ESTIMATED |
READOUT
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis As
Phase 3 · Psychosis Associated With Alzheimer's Disease |
Karuna Therapeutics, Inc., a Brist | KarXT |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|